http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2750409-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63cc3906e2bf87b53f9de79e7f2a79f5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fec86856bcf950c92d84dddd615734e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc5893569c4b888078ad67bb92c3873a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daba88aca236538c0fa5e4f8001eed40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7172dfe974a8b17ee4556dd98d30ac3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67201ef65cbeddbcccbee48304192cfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2425de7f50cdf66bed1334010c4c7b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_517d3c48691fa42ce8af87d3f2bfb8b4 |
| publicationDate | 2021-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2750409-C1 |
| titleOfInvention | Method for personalized prediction of the development of complications in patients with acute abdominal diseases |
| abstract | FIELD: medicine.SUBSTANCE: invention relates to medicine, in particular to abdominal surgery and resuscitation, and is intended for personalized prediction of the development of complications in patients with acute abdominal diseases. In patients in the early postoperative period, on days 2-4, the blood plasma toxicity index, the amount of triene conjugates and the activity of phospholipase А2are determined. The presence of mitochondrial superoxide dismutase 2 (SOD2) gene polymorphism is determined once. The index for predicting the development of complications is calculated using theformula, the IPRO value less than 2.0 indicates the absence of the likelihood of complications. An IPRO value of 2.1 to 3.4 indicates a low likelihood of complications. An IPRO value of 3.5 or more indicates a high degree of likelihood of complications.EFFECT: invention provides increased accuracy of predicting the course of the early postoperative period in patients with acute abdominal diseases.1 cl, 4 tbl, 3 ex |
| priorityDate | 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 263.